CLINICAL_TRIALS
trial_result
· 2009-05-13
Clinical Trial Update: Role of Mosapride in Patients With Gastroesophageal Reflux Disease [Phase 4]
Summary
A Phase 4 trial evaluating mosapride for gastroesophageal reflux disease has completed.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Lotung Poh-Ai Hospital | Conditions: Gastroesophageal Reflux Disease | Phase 4 | Status: COMPLETED